We are pleased to announce that after many years of planning and collaboration, SHOT has introduced reporting in 4 categories for the UK Blood Services from 5th August 2025.
Blood services will submit a report where an error has occurred in the diagnostic laboratories and issuing departments in the UK Blood Services that led to erroneous results given, or blood components issued to healthcare organisations with potential to cause harm to patients. This development marks a significant step forward in strengthening haemovigilance monitoring, learning from, and improving transfusion safety across the system. The new reporting pathway will support a more complete picture of events across the blood supply chain and help identify opportunities for system-wide improvement and shared learning.
The initial blood services reporting categories are:
• IBCI-WCI (Incorrect Blood Component Issued – Wrong Component Issued)
• IBCI-SRNM (Incorrect Blood Component Issued – Specific Requirements Not Met)
• Anti-D immunoglobulin (Ig) errors for blood services
• ACE (Acknowledging Continuing Excellence)
These categories will be reviewed periodically, and additional categories will be added over time. It is important to note that the UK Blood Services will continue to submit reportable incidents to MHRA via SABRE as per current regulatory requirements.
Further details to facilitate reporting (including a specific Blood Services definitions document) can be found here: https://www.shotuk.org/reporting/incident/blood-services-reporting-criteria/
